Similarly, increased TIM-3 expression and decreased IFNγ expression were demonstrated in tumor-infiltrating CD8+ T cells in a syngeneic glioma mouse model, although potential changes in BAT3, FOXO1, BLIMP1, and CD69 expression were not reported in this study [32]. This evidence concerns the gene PRDM1 and central nervous system cancer.